RT

Robert Thomas

Starpharma Holdings Limited | Non-Executive Director, Non-Executive Chairman
Mr Thomas has a strong background in financial services and capital markets and is a non executive director of several Australian listed companies. He was previously a Partner of Potter, where he was also Head of Research. He is the former Chief Executive Officer (CEO) of County NatWest Securities and then became CEO and then Chairman of Citibank Corporate and Investment Bank in Australia. He is also Chair of AusBio Ltd, Grahger Investments, Chair of the State Library of NSW Foundation and a director of O Connell Street Associates. He has expertise in Mergers & Acquisition (M&A) and capital markets including advising on the floats of Commonwealth Bank of Australia and Qantas, and experience in Audit and Risk Management. He is also approved under the NSW prequalification scheme for Audit and Risk Committee Independent Chairs and Members for government/public sector agencies and has previously served as the Chairman of the Audit and Risk Committee of Virgin Australia Limited, HeartWare International Inc, REVA Medical Limited and the State Library of NSW. He is Member of Risk Committee.

Company and Roles

Company
Title
Tenure
Since
SPL
Starpharma Holdings Limited
  • Non-Executive Director
  • Non-Executive Chairman
12yrs, 8mthDec 2013

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
SPL
Starpharma Holdings Limited
11/08/261,076,6672,773,334N/AN/A
06/02/26N/A11,200,0001,400,000N/A
23/08/24575,000600,000N/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
SPL
Starpharma Holdings Limited
11/08/26
Issued
126,667$0.570$72,200Rights issue
SPL
Starpharma Holdings Limited
11/08/26
Issued
223,334$0.570$127,300Rights issue
19/12/25
Issued
1,400,000$0.003$4,200Rights issue
19/12/25
Issued
2,800,000$0.003$8,400Rights issue
SPL
Starpharma Holdings Limited
16/10/25
Buy
450,000$0.279$125,471On-market trade